Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS)

Objective the dominant epitopes of T and B cells of VirB8 and VirB10 of Brucella type IV. Secretory systems were predicted and analyzed by bioinformatics, and then multi-epitope vaccines were constructed by reverse vaccination. Methods The amino acid sequences of VirB8 and VirB10 were obtained from the UniProt database, T and B cell dominant epitopes were selected and supplemented with adjuvants to construct a multi-epitope vaccine, SOPMA and RoseTTAFold were applied to predict secondary and tertiary structures respectively for immune simulations. Finally, molecular dynamics simulations of iMEV-TLR4 were then performed. Results one cytotoxic T lymphocyte (CTL) epitope, five helper T lymphocyte (HTL) epitopes, two linear B cell epitopes and three conformational B cell epitopes were obtained in VirB8. 1 cytotoxic T lymphocyte (CTL) epitope, 4 helper T lymphocyte (HTL) epitopes, 4 linear B cell epitopes, and 3 conformational B cell epitopes were obtained in VirB10. The resulting multiepitope vaccine is a protein with good antigenicity, hydrophilicity, and stability. Conclusion a novel brucella multiepitope vaccine was designed by reverse vaccination, and this study provides a theoretical basis for further research.